MagDI Canada Study
NCT: NCT06467955 · ACTIVE_NOT_RECRUITING
広告
NCT識別子NCT06467955
ステータスACTIVE_NOT_RECRUITING
開始日2024-05-10
SponsorGT Metabolic Solutions, Inc. (INDUSTRY)
First posted
Last updated
概要
The objective of the MagDI Canada study is to evaluate the performance and safety of the MagDI System in eligible participants who are indicated for a duodeno-ileal (small bowel) side-to-side anastomosis procedure for partial intestinal diversion as one example of a small bowel clinical procedure requiring a side-to-side anastomosis. The secondary objective includes initial efficacy of the duodeno-ileal diversion using the MagDI System.
公式ソース
ClinicalTrials.govで見る →データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。